Condensed Consolidated Statements of Operations (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Revenues
Revenues	$ 657,640	[1]	$ 753,063	[1]
Costs and Expenses
Cost of revenues (exclusive of depreciation shown below)	1,581,493		0
Research, development and manufacturing operations (exclusive of depreciation shown below)	1,716,387		3,817,136
Selling, general and administrative (exclusive of depreciation shown below)	2,840,799		3,044,099
Depreciation and amortization	1,440,266		1,470,149
Total Costs and Expenses	7,578,945		8,331,384
Loss from Operations	(6,921,305)		(7,578,321)
Other Income, net	17,853		552
Loss on extinguishment of liabilities	(2,610,152)		(351,521)
Interest expense	(9,951,760)		(105,480)
Deemed interest expense on warrant liability	(909,092)		0
Change in fair value of derivative liabilities	2,586,686		(735,454)
Total Other Income/(Expense)	(10,866,465)		(1,191,903)
Net Loss	(17,787,770)		(8,770,224)
Deemed dividend on Preferred Stock and accretion of warrants	0		(2,920,000)
Net Loss applicable to common stockholders	$ (17,787,770)		$ (11,690,224)
Net Loss Per Share (Basic and diluted) (in dollars per share)	$ (0.79)		$ (1.77)
Weighted Average Common Shares Outstanding (Basic and diluted) (in shares)	22,440,851		6,603,665

[1] Includes related party revenue of $8,050 for the three months ended March 31, 2014.